Arca Biopharma | ABIO - Net Income


Arca Biopharma reported $-29.58M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
Arca Biopharma USD -29.58M 694K Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 6.76B 6.75B Dec/2025
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD 56.84M 63.82M Dec/2025
CSL USD 401M 96.5M Dec/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Daiichi Sankyo JPY 86.63B 41.32B Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Grifols EUR 114.37M 34.03M Dec/2025
Laboratory Of America USD 164.7M 96.4M Dec/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
Otsuka Holdings JPY 65.49B 58.64B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
United Therapeutics USD 364.3M 25.6M Dec/2025